The Impact of an Efflux Pump Inhibitor on the Activity of Free and Liposomal Antibiotics against <i>Pseudomonas aeruginosa</i>
The eradication of <i>Pseudomonas aeruginosa</i> in cystic fibrosis patients has become continuously difficult due to its increased resistance to treatments. This study assessed the efficacy of free and liposomal gentamicin and erythromycin, combined with Phenylalanine arginine beta-naph...
Main Authors: | Douweh Leyla Gbian, Abdelwahab Omri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/4/577 |
Similar Items
-
Role of Efflux Pumps on Antimicrobial Resistance in <i>Pseudomonas aeruginosa</i>
by: Andre Bittencourt Lorusso, et al.
Published: (2022-12-01) -
MexXY multidrug efflux system of Pseudomonas aeruginosa
by: Yuji eMorita, et al.
Published: (2012-11-01) -
Evaluation of Heterocyclic Carboxamides as Potential Efflux Pump Inhibitors in <i>Pseudomonas aeruginosa</i>
by: Yi Yuan, et al.
Published: (2021-12-01) -
Aminoglycoside-Modifying Enzymes Are Sufficient to Make <i>Pseudomonas aeruginosa</i> Clinically Resistant to Key Antibiotics
by: Aswin Thacharodi, et al.
Published: (2022-07-01) -
Berberine is a novel type efflux inhibitor which attenuates the MexXY-mediated aminoglycoside resistance in Pseudomonas aeruginosa.
by: Yuji Morita, et al.
Published: (2016-08-01)